Co-delivery of curcumin and Bcl-2 siRNA by PAMAM dendrimers for enhancement of the therapeutic efficacy in HeLa cancer cells

被引：99
|
作者：
Ghaffari, Maryam [1 ,2 ,3 ]
Dehghan, Gholamreza [2 ]
Baradaran, Behzad [4 ]
Zarebkohan, Amir [5 ]
Mansoori, Behzad [4 ]
Soleymani, Jafar [6 ]
Dolatabadi, Jafar Ezzati Nazhad [7 ]
Hamblin, Michael R. [8 ,9 ,10 ]
机构：
[1] Tabriz Univ Med Sci, Res Ctr Pharmaceut Nanotechnol, Tabriz, Iran
[2] Univ Tabriz, Fac Nat Sci, Dept Biol, Tabriz, Iran
[3] Tabriz Univ Med Sci, Student Res Comm, Tabriz, Iran
[4] Tabriz Univ Med Sci, Immunol Res Ctr, Tabriz, Iran
[5] Tabriz Univ Med Sci, Fac Adv Med Sci, Dept Med Nanotechnol, Tabriz, Iran
[6] Tabriz Univ Med Sci, Pharmaceut Anal Res Ctr, Tabriz, Iran
[7] Tabriz Univ Med Sci, Drug Appl Res Ctr, Tabriz, Iran
[8] Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA
[9] Harvard Med Sch, Dept Dermatol, Boston, MA 02115 USA
[10] Univ Johannesburg, Fac Hlth Sci, Laser Res Ctr, ZA-2028 Doornfontein, South Africa
来源：
COLLOIDS AND SURFACES B-BIOINTERFACES | 2020年 / 188卷
关键词：
Curcumin; Bcl-2; siRNA; PAMAM dendrimer; Co-delivery; HeLa cancer cells; Nanoparticles; DENDROSOMAL CURCUMIN; ANTICANCER ACTIVITY; INDUCE APOPTOSIS; BREAST-CANCER; IN-VITRO; NANOPARTICLES; DRUG; DOXORUBICIN; CISPLATIN; PATHWAYS;
D O I：
10.1016/j.colsurfb.2019.110762
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
Co-delivery of therapeutic agents and small interfering RNA (siRNA) can be achieved by a suitable nanovehicle. In this work, the solubility and bioavailability of curcumin (Cur) were enhanced by entrapment in a poly-amidoamine (PAMAM) dendrimer, and a polyplex was formed by grafting Bcl-2 siRNA onto the surface amine groups to produce PAMAM-Cur/Bcl-2 siRNA nanoparticles (NPs). The synthesized polyplex NPs had a particle size of similar to 180 nm, and high Cur loading content of similar to 82 wt%. Moreover, the PAMAM-Cur/Bcl-2 siRNA NPs showed more effective cellular uptake, and higher inhibition of tumor cell proliferation compared to PAMAM-Cur nanoformulation and free Cur, due to the combined effect of co-delivery of Cur and Bcl-2 siRNA. The newly described PAMAM-Cur/Bcl-2 siRNA polyplex NPs could be a promising co-delivery nanovehicle.
引用
收藏
页数：11
相关论文
共 50 条
  • [21] Co-delivery of doxorubicin and TRAIL plasmid by modified PAMAM dendrimer in colon cancer cells, in vitro and in vivo evaluation
    Pishavar, Elham
    Ramezani, Mohammad
    Hashemi, Maryam
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2019, 45 (12) : 1931 - 1939
  • [22] Co-delivery of siRNA and etoposide to cancer cells using an MDEA esterquat based drug delivery system
    Popova, Petya
    Notabi, Martine Khataei
    Code, Christian
    Arnspang, Eva C.
    Andersen, Morten Ostergaard
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 127 : 142 - 150
  • [23] Study on co-delivery of pemetrexed disodium and Bcl-2 siRNA by poly-γ-glutamic acid-modified cationic liposomes for the inhibition of NSCLC
    Huang, Xiaoyu
    Song, Ruonan
    Wang, Xiao
    He, Kongfang
    Shan, Rumeng
    Xie, Fei
    Huang, Guihua
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2023, 49 (01) : 62 - 74
  • [24] Co-Delivery Using pH-Sensitive Liposomes to Pancreatic Cancer Cells: the Effects of Curcumin on Cellular Concentration and Pharmacokinetics of Gemcitabine
    Xu, Hongtao
    Li, Yan
    Paxton, James W.
    Wu, Zimei
    PHARMACEUTICAL RESEARCH, 2021, 38 (07) : 1209 - 1219
  • [25] Co-delivery of curcumin and quercetin in shellac nanocapsules for the synergistic antioxidant properties and cytotoxicity against colon cancer cells
    Jain, Surangna
    Lenaghan, Scott
    Dia, Vermont
    Zhong, Qixin
    FOOD CHEMISTRY, 2023, 428
  • [26] Non-Viral Systems Based on PAMAM-Calix-Dendrimers for Regulatory siRNA Delivery into Cancer Cells
    Padnya, Pavel
    Shiabiev, Igor
    Pysin, Dmitry
    Gerasimova, Tatiana
    Ranishenka, Bahdan
    Stanavaya, Alesia
    Abashkin, Viktar
    Shcharbin, Dzmitry
    Shi, Xiangyang
    Shen, Mingwu
    Nazarova, Anastasia
    Stoikov, Ivan
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (23)
  • [27] Co-delivery of siRNA and doxorubicin to cancer cells from additively manufactured implants
    Chen, Muwan
    Andersen, Morten O.
    Dillschneider, Philipp
    Chang, Chi-Chih
    Gao, Shan
    Le, Dang Q. S.
    Yang, Chuanxu
    Hein, San
    Buenger, Cody
    Kjems, Jorgen
    RSC ADVANCES, 2015, 5 (123): : 101718 - 101725
  • [28] Co-delivery of AKT3 siRNA and PTEN Plasmid by Antioxidant Nanoliposomes for Enhanced Antiproliferation of Prostate Cancer Cells
    Bhagat, Stuti
    Singh, Sanjay
    ACS APPLIED BIO MATERIALS, 2020, 3 (07): : 3999 - 4011
  • [29] A new liposomal nanocarrier for co-delivery of gedunin and p-glycoprotein siRNA to target breast cancer stem cells
    Rana, Mohan Singh
    Ediriweera, Meran Keshawa
    Rajagopalan, Umapriyatharshini
    Karunaratne, Desiree Nedra
    Tennekoon, Kamani Hemamala
    Samarakoon, Sameera Ranganath
    NATURAL PRODUCT RESEARCH, 2022, 36 (24) : 6389 - 6392
  • [30] Therapeutic Silencing of Bcl-2 by Systemically Administered siRNA Nanotherapeutics Inhibits Tumor Growth by Autophagy and Apoptosis and Enhances the Efficacy of Chemotherapy in Orthotopic Xenograft Models of ER (-) and ER (+) Breast Cancer
    Tekedereli, Ibrahim
    Alpay, S. Neslihan
    Akar, Ugur
    Yuca, Erkan
    Ayugo-Rodriguez, Cristian
    Han, He-Dong
    Sood, Anil K.
    Lopez-Berestein, Gabriel
    Ozpolat, Bulent
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2013, 2 : e121
12345